State Street
VCNX

State Street’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

State Street’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-340
Closed -$25.4K – 4615
2023
Q2 		$25.4K Hold
340
– – ﹤0.01% 4561
2023
Q1 		$28.5K Hold
340
– – ﹤0.01% 4630
2022
Q4 		$47.1K Hold
340
– – ﹤0.01% 4572
2022
Q3 		$35K Hold
340
– – ﹤0.01% 4734
2022
Q2 		$77K Buy
340
+17
+5% +$4.34K ﹤0.01% 4617
2022
Q1 		$89K Hold
323
– – ﹤0.01% 4677
2021
Q4 		$71K Hold
323
– – ﹤0.01% 4642
2021
Q3 		$146K Buy
323
+3
+0.9% +$1.5K ﹤0.01% 4458
2021
Q2 		$188K Buy
+320
New +$169K ﹤0.01% 4230

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $169M AUM 24.7% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return